MetLife director awarded 721 shares in stock grant

Glaser Daniel S reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Glaser Daniel S reported acquisition or exercise transactions in this Form 4 filing.

MetLife Inc. director Daniel S. Glaser received an equity award of 721 shares of common stock, valued at $71.17 per share. The award represents a portion of his non-management director retainer fees paid in stock. He elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Following this grant, Glaser directly holds 2,101 shares of MetLife common stock. In addition, 198 shares are held indirectly in a GRAT, reflecting an estate-planning vehicle associated with his holdings.

Insider Trade Summary

Grant/Award: 721 shares

Grant/Award 2 txns

Insider Glaser Daniel S

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	721	$71.17	$51K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 2,101 shares (Direct); Common Stock — 198 shares (Indirect, By GRAT)

Footnotes (2)

1. F1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
2. F2. These shares are held in a GRAT.

Key Figures

Equity award: 721 shares Grant valuation price: $71.17 per share Direct holdings after grant: 2,101 shares +1 more

4 metrics

Equity award 721 shares Common stock grant to director Daniel S. Glaser

Grant valuation price $71.17 per share Value used for the 721-share stock award

Direct holdings after grant 2,101 shares MetLife common stock held directly by Glaser after transaction

Indirect GRAT holdings 198 shares MetLife common stock held indirectly in a GRAT

Key Terms

MetLife Deferred Compensation Plan for Non-Management Directors, GRAT, retainer fees

3 terms

MetLife Deferred Compensation Plan for Non-Management Directors financial

"The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."

GRAT financial

"These shares are held in a GRAT."

retainer fees financial

"non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock."

FAQ

What insider transaction did MetLife (MET) director Daniel Glaser report?

Daniel S. Glaser reported receiving 721 shares of MetLife common stock as an equity award. The shares were granted as part of his non-management director retainer fees, which MetLife partially pays in common stock instead of entirely in cash.

At what price was Daniel Glaser’s MetLife (MET) stock award valued?

The 721-share award to Daniel Glaser was valued at $71.17 per share. This price is used in the Form 4 to represent the grant’s value for reporting purposes, helping investors understand the approximate dollar size of the compensation-related equity award.

How many MetLife (MET) shares does Daniel Glaser hold after this transaction?

After the award, Daniel Glaser directly holds 2,101 shares of MetLife common stock. The Form 4 also shows an additional 198 shares held indirectly in a GRAT, giving a clearer picture of his total reported economic exposure to MetLife stock.

What does it mean that Daniel Glaser deferred his MetLife (MET) stock award?

Glaser elected to defer receipt of the 721 awarded shares under MetLife’s Deferred Compensation Plan for Non-Management Directors. Deferral means he does not immediately take delivery of the shares, which can align equity compensation with long-term incentives and tax planning goals.

What is the significance of MetLife (MET) shares held in a GRAT for Daniel Glaser?

The Form 4 notes that 198 MetLife shares are held in a GRAT. A GRAT, or grantor retained annuity trust, is an estate-planning structure. Listing these shares separately highlights that this portion of Glaser’s holdings is owned through a specialized trust arrangement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/03/2026 - 04:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glaser Daniel S

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A(1)		721	A	$71.17	2,101	D
Common Stock								198(2)	I	By GRAT

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

2. These shares are held in a GRAT.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)